John E. Jett, PhD
About John E. Jett, PhD
John E. Jett, PhD, serves as the Vice President of Clinical Development & Clinical Pharmacology at Beyond Air®, where he has worked since 2023. He has a strong background in clinical pharmacology and drug development, having held various roles in the pharmaceutical industry over the past two decades.
Work at Beyond Air
John E. Jett, PhD, serves as the Vice President of Clinical Development & Clinical Pharmacology at Beyond Air®, a position he has held since 2023. In this role, he is responsible for developing global Clinical Development and Clinical Pharmacology strategies for multiple indications. His expertise in clinical pharmacology and drug development supports the company's mission to advance innovative therapies.
Previous Experience in Clinical Development
Prior to joining Beyond Air®, John E. Jett worked at Dermavant Sciences as the Director of Clinical Development from 2017 to 2022. During his five-year tenure, he contributed to the advancement of clinical development strategies in dermatology. He also held the position of Clinical Development Scientist at Viamet Pharmaceuticals from 2015 to 2017, where he played a key role in the development of clinical programs.
Education and Expertise
John E. Jett earned a prestigious NSF/WV EPSCoR STEM Fellowship during his graduate studies at West Virginia University, where he was a Graduate Fellow from 2004 to 2011. His educational background has provided him with extensive knowledge in clinical pharmacology and drug metabolism and pharmacokinetics (DMPK), which he has applied throughout his career in various roles.
Career Background
John E. Jett has a diverse professional background in the pharmaceutical industry. He worked at Targacept, Inc. as Program Leader/Senior Scientist in DMPK and Clinical Pharmacology from 2011 to 2015, leading program initiatives in this area. Earlier in his career, he gained experience as a Quality Control Microbiology Technician at Cargill from 2001 to 2002.